Working... Menu

Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of UB-311 in Mild Alzheimer's Disease (AD) Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02551809
Recruitment Status : Completed
First Posted : September 16, 2015
Last Update Posted : January 23, 2019
Information provided by (Responsible Party):
United Neuroscience Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2018
  Actual Study Completion Date : August 2018